Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 1
1966 2
1967 2
1968 4
1969 4
1970 3
1971 3
1972 5
1973 4
1974 11
1975 8
1976 16
1977 18
1978 33
1979 34
1980 31
1981 28
1982 55
1983 63
1984 59
1985 58
1986 77
1987 78
1988 74
1989 95
1990 129
1991 144
1992 136
1993 145
1994 197
1995 175
1996 195
1997 239
1998 231
1999 247
2000 289
2001 342
2002 314
2003 393
2004 457
2005 467
2006 542
2007 590
2008 653
2009 684
2010 773
2011 905
2012 990
2013 1031
2014 1238
2015 1321
2016 1440
2017 1539
2018 1634
2019 1758
2020 2159
2021 2658
2022 2719
2023 2832
2024 1155

Text availability

Article attribute

Article type

Publication date

Search Results

28,678 results

Results by year

Filters applied: . Clear all
Page 1
Do generic drugs cause hypersensitivity?
Tetart F, Gonde H, Hervouët C. Tetart F, et al. Eur J Dermatol. 2022 Sep 1;32(5):571-576. doi: 10.1684/ejd.2022.4291. Eur J Dermatol. 2022. PMID: 36468717 Free PMC article. Review.
Generic drugs may differ from brand-name drugs in nature and quantity of excipients. ...No scientific rationale has emerged for labelling patients allergic to all generic drugs, and hypersensitivity to generic drugs may rather be e
Generic drugs may differ from brand-name drugs in nature and quantity of excipients. ...No scientific rationale has eme
Current Challenges in Labelling for Generic Medicinal Products: Company Core Data Sheet (CCDS) Development and Maintenance.
Mueller M, Lewis DJ, Darisi VKK, Horn S. Mueller M, et al. Pharmaceut Med. 2020 Dec;34(6):381-386. doi: 10.1007/s40290-020-00364-7. Epub 2020 Dec 8. Pharmaceut Med. 2020. PMID: 33289912 Free PMC article.
This information may be provided to end-users including patients and/or prescribers, and it needs to be made available in multiple formats including printed forms (patient information leaflets, pack inserts, etc.) or web portals of the product, based on national authority …
This information may be provided to end-users including patients and/or prescribers, and it needs to be made available in multiple formats i …
Science of Biosimilars.
Harvey RD. Harvey RD. J Oncol Pract. 2017 Sep;13(9_suppl):17s-23s. doi: 10.1200/JOP.2017.026062. J Oncol Pract. 2017. PMID: 28898589 Review.
Regulatory agencies expect these differences to be identified, analyzed, and minimized through iterative processes and extensive preclinical efforts. Generic naming of biosimilars reflects the nonproprietary reference product name along with a meaningless four-lette …
Regulatory agencies expect these differences to be identified, analyzed, and minimized through iterative processes and extensive preclinical …
Site-Specific and Country-of-Origin Labeling for Pharmaceutical Manufacturing.
Hatton RC, Leighton G, Englander L. Hatton RC, et al. Ann Pharmacother. 2022 Oct;56(10):1184-1187. doi: 10.1177/10600280211069541. Epub 2022 Jan 13. Ann Pharmacother. 2022. PMID: 35023388
There is increasing concern about the quality of pharmaceuticals, especially generics made in Asia. Popular books and news reports have the public questioning the quality of pharmaceuticals. Recalls and import bans shake confidence in medications, particularly for active p …
There is increasing concern about the quality of pharmaceuticals, especially generics made in Asia. Popular books and news reports ha …
The Power of Labeling in Nocebo Effects.
Faasse K, Martin LR. Faasse K, et al. Int Rev Neurobiol. 2018;139:379-406. doi: 10.1016/bs.irn.2018.07.016. Epub 2018 Aug 6. Int Rev Neurobiol. 2018. PMID: 30146055 Review.
One source of negative expectations is the presence of generic-as opposed to brand name-labeling. A medicine's labeling is likely to be one of the first aspects of a treatment that is encountered by a patient, and perhaps the most common labeling information on pharmaceuti …
One source of negative expectations is the presence of generic-as opposed to brand name-labeling. A medicine's labeling is likely to …
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE).
Roberti R, Casarella A, Iudice A, La Neve A, Beghi E, Capovilla G, Di Bonaventura C, Giorgi FS, Grosso S, Iannone LF, Romigi A, Specchio LM, Zaccara G, Mecarelli O, Russo E; Antiseizure Medications Commission of the Italian League against Epilepsy LICE. Roberti R, et al. Epilepsy Behav. 2021 Mar;116:107804. doi: 10.1016/j.yebeh.2021.107804. Epub 2021 Feb 10. Epilepsy Behav. 2021. PMID: 33581599 Review.
Generic drugs are increasingly used to treat many diseases including epilepsy. ...Compared with the previous literature review, randomized controlled trials assessing bioequivalence among branded drugs and generics are currently available. Although som
Generic drugs are increasingly used to treat many diseases including epilepsy. ...Compared with the previous literature review
Package Design Affects Accuracy Recognition for Medications.
Endestad T, Wortinger LA, Madsen S, Hortemo S. Endestad T, et al. Hum Factors. 2016 Dec;58(8):1206-1216. doi: 10.1177/0018720816664824. Epub 2016 Sep 1. Hum Factors. 2016. PMID: 27591209 Free PMC article.
METHOD: In two experiments, we compared the original packaging with packages where we varied placement of the name, dose, and background of the active ingredient. ...This kind of error decreased with the redesigned packages (young, 8%, and elderly, 16%). Conf …
METHOD: In two experiments, we compared the original packaging with packages where we varied placement of the name, dose, and …
Aids for eye drop administration.
Davies I, Williams AM, Muir KW. Davies I, et al. Surv Ophthalmol. 2017 May-Jun;62(3):332-345. doi: 10.1016/j.survophthal.2016.12.009. Epub 2016 Dec 21. Surv Ophthalmol. 2017. PMID: 28011246 Review.
Difficulties may include aiming their drops, extending their neck, preventing excess drop leakage, avoiding contamination of the bottle tip, and generating enough force to expel a drop from the bottle. Instillation aids are devices that aim to ameliorate one or more of the …
Difficulties may include aiming their drops, extending their neck, preventing excess drop leakage, avoiding contamination of the bottle tip, …
Controversy over generic substitution.
Emery J, McKenzie A, Bulsara C, Holman D. Emery J, et al. BMJ. 2010 Jul 7;341:c3570. doi: 10.1136/bmj.c3570. BMJ. 2010. PMID: 20610498 No abstract available.
Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
Sillo HB, Masota NE, Kisoma S, Rago L, Mgoyela V, Kaale EA. Sillo HB, et al. PLoS One. 2018 May 22;13(5):e0197490. doi: 10.1371/journal.pone.0197490. eCollection 2018. PLoS One. 2018. PMID: 29787579 Free PMC article.
The parameter with the lowest observed percentage conformity among the branded products scored 50% as compared to 10.8% among the generic products. Moreover, there was no significant difference (P<0.05) in the percentage conformity of the package inserts collecte …
The parameter with the lowest observed percentage conformity among the branded products scored 50% as compared to 10.8% among the generic
28,678 results
You have reached the last available page of results. Please see the User Guide for more information.